Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TriLink Biotechnologies has signed a service agreement with Applied Biosystems to supply reagents for Applied Biosystems' recently launched next-generation genetic analysis platform, the SOLiD system.
Subscribe to our email newsletter
Under the terms of the agreement, TriLink is providing Applied Biosystems with custom dye-labeled oligonucleotides, or chemically synthesized nucleotides, which are used as part of the DNA sequencing process.
Kim Caple, vice president and general manager for Applied Biosystems’ next-generation sequencing business, said: “Working with best-in-class suppliers like TriLink has enabled us to develop the most robust, accurate, and highest-throughput genetic analysis platform available to help our customers take advantage of the emerging applications for next-generation DNA sequencing.”
Dr. Richard Hogrefe, CEO of TriLink, said: “We are proud that Applied Biosystems has chosen TriLink to be the supplier of the oligonucleotides used in the SOLiD system.”